Target intelligence / Profile preview

Mitotic kinesin-like protein 1 (MKLP1)

Target
MKLP1
Molecular classification
Enzyme (microtubule-dependent molecular motor protein), Motor protein, Kinesin superfamily, Kinesin-6 family
01

Overview

Mitotic kinesin-like protein 1 (MKLP1, also known as KIF23 or CHO1) is a plus end–directed microtubule-dependent motor protein and a key component of the centralspindlin complex, required for cytokinesis in animal cells[4][7][8]. MKLP1 cross-bridges antiparallel microtubules of the central spindle during anaphase and becomes concentrated in the midbody during cytokinesis, where it drives the formation of the cleavage furrow and completion of cell division[7][8][9]. In neurons, MKLP1 contributes to the regulation of microtubule transport and dendrite formation[7]. Dysfunction or overexpression of MKLP1 has been linked to cancer and possibly hereditary cell division disorders[8][9]. As it is essential in rapidly dividing cells, MKLP1 is regarded as a potential anti-cancer drug target[8].

Other names
KIF23CHO1Kinesin family member 23Mitotic kinesin-like protein 1Kinesin-6ZEN-4Pavarotti
02

Mechanism of action

Inhibition of motor activity: Drugs targeting MKLP1/KIF23 would be expected to block its ATPase/microtubule-interacting functions, leading to failed cytokinesis and cancer cell death. Disruption of spindle assembly and furrow ingression

03

Biological functions

Cytokinesis (essential for cleavage furrow formation and completion of cell division)Cell cycle regulationMitotic spindle organizationCentral spindle formationCell divisionIn neurons: regulation of microtubule transport and dendrite morphogenesis
04

Disease associations

Cancer (abnormal expression and function implicated in tumorigenesis)Hereditary congenital conditions (e.g., described in context of cell division errors)Other cell division-related pathologies
05

Safety considerations

Potential for off-target effects in proliferating normal cells (e.g., bone marrow, gut epithelium)Possible aneuploidy, multinucleation, or failed cell division in non-cancerous tissues
06

Biomarkers

Elevated expression in tumor tissue may serve as a cancer biomarker

Beyond the preview

Go deeper on Mitotic kinesin-like protein 1 (MKLP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitotic kinesin-like protein 1 (MKLP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call